Toll-like receptor (TLR) expression on CD4+ and CD8+ T-cells in patients chronically infected with hepatitis C virus

Cellular Immunology

Volumn 264, Issue 2, 2010, Pages 150-155

  Hammond, Talia ^a   Lee, Silvia ^a,b   Watson, Mark W ^b   Flexman, James P ^a   Cheng, Wendy ^b   Fernandez, Sonia ^a   Price, Patricia ^a,b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b ROYAL PERTH HOSPITAL   (Australia)

Author keywords

HCV; RIG I; Therapy; TLR

Indexed keywords

CD4 ANTIGEN; CD45RA ANTIGEN; CD57 ANTIGEN; CD8 ANTIGEN; GENE PRODUCT; PEGINTERFERON ALPHA; RETINOIC ACID INDUCIBLE PROTEIN I; RIBAVIRIN; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9; ALPHA INTERFERON; ALPHA2A INTERFERON; DDX58 PROTEIN, HUMAN; DEAD BOX PROTEIN; LEUKOCYTE ANTIGEN; MACROGOL DERIVATIVE; PEGINTERFERON ALPHA2A; RECOMBINANT PROTEIN;

ADULT; AGED; ANTIGEN SPECIFICITY; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EFFECTOR CELL; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HEPATITIS C; HUMAN; IMMUNE RESPONSE; LYMPHOCYTE SUBPOPULATION; MALE; MEMORY CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TREATMENT RESPONSE; BIOSYNTHESIS; CELL SEPARATION; DRUG EFFECTS; GENETICS; HEPACIVIRUS; HEPATITIS C, CHRONIC; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PATHOGENICITY; PATHOLOGY; PATHOPHYSIOLOGY;

ADULT; AGED; ANTIGENS, CD; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL SEPARATION; DEAD-BOX RNA HELICASES; FEMALE; FLOW CYTOMETRY; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; IMMUNOLOGIC MEMORY; INTERFERON ALFA-2A; MALE; MIDDLE AGED; POLYETHYLENE GLYCOLS; RIBAVIRIN; TOLL-LIKE RECEPTORS; INTERFERON-ALPHA; RECOMBINANT PROTEINS;

HEPATITIS C VIRUS;

EID: 77955095220     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2010.06.001     Document Type: Article

References (39)

1. Seki E., Brenner D.A. Toll-like receptors and adaptor molecules in liver disease: update. Hepatology 2008, 48:322-335.
2. Thompson A.J., Locarnini S.A. Toll-like receptors, RIG-I-like RNA helicases and the antiviral innate immune response. Immunol. Cell Biol. 2007, 85:435-445.
3. He Q., Graham C.S., Durante Mangoni E., Koziel M.J. Differential expression of toll-like receptor mRNA in treatment non-responders and sustained virologic responders at baseline in patients with chronic hepatitis C. Liver Int. 2006, 26:1100-1110.
4. Dolganiuc A., Garcia C., Kodys K., Szabo G. Distinct Toll-like receptor expression in monocytes and T cells in chronic HCV infection. World J. Gastroenterol. 2006, 12:1198-1204.
5. Sato K., Ishikawa T., Okumura A., Yamauchi T., Sato S., Ayada M., et al. Expression of Toll-like receptors in chronic hepatitis C virus infection. J. Gastroenterol. Hepatol. 2007, 22:1627-1632.
6. Miyazaki M., Kanto T., Inoue M., Itose I., Miyatake H., Sakakibara M., Yakushijin T., Kakita N., Hiramatsu N., Takehara T., Kasahara A., Hayashi N. Impaired cytokine response in myeloid dendritic cells in chronic hepatitis C virus infection regardless of enhanced expression of Toll-like receptors and retinoic acid inducible gene-I. J. Med. Virol. 2008, 80:980-988.
7. Yonkers N.L., Rodriguez B., Milkovich K.A., Asaad R., Lederman M.M., Heeger P.S., Anthony D.D. TLR ligand-dependent activation of naive CD4 T cells by plasmacytoid dendritic cells is impaired in hepatitis C virus infection. J. Immunol. 2007, 178:4436-4444.
8. Rodrigue-Gervais I.G., Jouan L., Beaule G., Sauve D., Bruneau J., Willems B., et al. Poly(I:C) and lipopolysaccharide innate sensing functions of circulating human myeloid dendritic cells are affected in vivo in hepatitis C virus-infected patients. J. Virol. 2007, 81:5537-5546.
9. Babu S., Blauvelt C.P., Kumaraswami V., Nutman T.B. Diminished expression and function of TLR in lymphatic filariasis: a novel mechanism of immune dysregulation. J. Immunol. 2005, 175:1170-1176.
10. Dasari P., Nicholson I.C., Hodge G., Dandie G.W., Zola H. Expression of toll-like receptors on B lymphocytes. Cell Immunol. 2005, 236:140-145.
11. Månsson A., Adner M., Höckerfelt U., Cardell L.O. A distinct Toll-like receptor repertoire in human tonsillar B cells, directly activated by PamCSK, R-837 and CpG-2006 stimulation. Immunology 2006, 118:539-548.
12. Hornung V., Rothenfusser S., Britsch S., Krug A., Jahrsdörfer B., Giese T., Endres S., Hartmann G. Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J. Immunol. 2002, 168:4531-4537.
13. Mansson A., Adner M., Cardell L.O. Toll-like receptors in cellular subsets of human tonsil T cells: altered expression during recurrent tonsillitis. Respir. Res. 2006, 27:7-36.
14. + T cells are similar to natural killer cells in response to infection with Venezuelan equine encephalitis virus replicons. J. Infect Dis. 2003, 188:1562-1570.
15. + T regulatory cells. J. Immunol. 2005, 175:8051-8059.
16. Bullock G.C., Bruns D.E., Haverstick D.M. Hepatitis C genotype determination by melting curve analysis with a single set of fluorescence resonance energy transfer probes. Clin. Chem. 2002, 48:2147-2154.
17. Castelain S., Descamps V., Thibault V., François C., Bonte D., Morel V., et al. TaqMan amplification system with an internal positive controls for HCV RNA quantitation. J. Clin. Virol. 2004, 31:227-234.
18. Bedossa P., Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 1996, 24:289-293.
19. S. Lee, T. Hammond, M.W. Watson, J.P. Flexman, W. Cheng, S. Fernandez, P. Price, Could a loss of memory T-cells limit responses to HCV antigens in blood leukocytes from patients chronically infected with hepatitis C virus before and during pegylated interferon-α and ribavirin therapy? Clin. Exp. Immunol., 9 April 2010 (Epub ahead of print).
20. Thimme R., Oldach D., Chang K.M., Steiger C., Ray S.C., Chisari F.V. Determinants of viral clearance and persistence during acute hepatitis C virus infection. J. Exp. Med. 2001, 194:1395-1406.
21. Babu S., Blauvelt C.P., Kumaraswami V., Nutman T.B. Cutting edge: diminished T cell TLR expression and function modulates the immune response in human filarial infection. J. Immunol. 2006, 176:3885-3889.
22. Prabha C., Rajashree P., Sulochana D.D. TLR2 and TLR4 expression on the immune cells of tuberculous pleural fluid. Immunol. Lett. 2008, 117:26-34.
23. Sanders C.M., Cruse J.M., Lewis R.E. Toll-like receptors, cytokines and HIV-1. Exp. Mol. Pathol. 2008, 84:31-36.
24. Zarember K.A., Godowski P.J. Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J. Immunol. 2002, 168:554-561.
25. Roelofs M.F., Wenink M.H., Brentano F., Abdollahi-Roodsaz S., Oppers-Walgreen B., Barrera P., van Riel P.L., Joosten L.A., Kyburz D., van den Berg W.B., Radstake T.R. Type I interferons might form the link between Toll-like receptor (TLR) 3/7 and TLR4-mediated synovial inflammation in rheumatoid arthritis (RA). Ann. Rheum. Dis. 2009, 68:1486-1493.
26. Hornung V., Ellegast J., Kim S., Brzózka K., Jung A., Kato H., Poeck H., Akira S., Conzelmann K.K., Schlee M., Endres S., Hartmann G. 5'-Triphosphate RNA is the ligand for RIG-I. Science 2006, 314:994-997.
27. Sumpter R., Loo Y.M., Foy E., Li K., Yoneyama M., Fujita T., Lemon S.M., Gale M. Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase. RIG-I, J Virol. 2005, 79:2689-2699.
28. Atencia R., Bustamante F.J., Valdivieso A., Arrieta A., Riñón M., Prada A., Maruri N. Differential expression of viral PAMP receptors mRNA in peripheral blood of patients with chronic hepatitis C infection. BMC Infect Dis. 2007, 7:136.
29. Komai-Koma M., Jones L., Ogg G.S., Xu D., Liew F.Y. TLR2 is expressed on activated T cells as a costimulatory receptor. Proc. Natl. Acad. Sci. USA 2004, 101:3029-3034.
30. Xu D., Komai-Koma M., Liew F.Y. Expression and function of Toll-like receptor on T cells. Cell Immunol. 2005, 233:85-89.
31. + T cells. J. Immunol. 2005, 175:1551-1557.
32. Mercier B.C., Cottalorda A., Coupet C.A., Marvel J., Bonnefoy-Bérard N. TLR2 engagement on CD8 T cells enables generation of functional memory cells in response to a suboptimal TCR signal. J. Immunol. 2009, 182:1860-1867.
33. Quigley M., Martinez J., Huang X., Yang Y. A critical role for direct TLR2-MyD88 signaling in CD8 T-cell clonal expansion and memory formation following vaccinia viral infection. Blood 2009, 113:2256-2264.
34. Funderburg N., Luciano A.A., Jiang W., Rodriguez B., Sieg S.F., Lederman M.M. Toll-like receptor ligands induce human T cell activation and death, a model for HIV pathogenesis. PLoS One 2008, 3:e1915.
35. + T cells more susceptible to productive infection with X4 and R5 HIV-type 1. J. Immunol. 2007, 179:4357-4366.
36. Song Y., Zhuang Y., Zhai S., Huang D., Zhang Y., Kang W., Li X., Liu Q., Yu Q., Sun Y. Increased expression of TLR7 in CD8(+) T cells leads to TLR7-mediated activation and accessory cell-dependent IFN-gamma production in HIV type 1 infection. AIDS Res. Hum. Retroviruses 2009, 25:1287-1295.
37. Abe T., Kaname Y., Hamamoto I., Tsuda Y., Wen X., Taguwa S., Moriishi K., Takeuchi O., Kawai T., Kanto T., Hayashi N., Akira S., Matsuura Y. Hepatitis C virus nonstructural protein 5A modulates the toll-like receptor-MyD88-dependent signaling pathway in macrophage cell lines. J. Virol. 2007, 81:8953-8966.
38. Li X.D., Sun L., Seth R.B., Pineda G., Chen Z.J. Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity. Proc. Natl. Acad. Sci. USA 2005, 102:17717-17722.
39. Otsuka M., Kato N., Moriyama M., Taniguchi H., Wang Y., Dharel N., Kawabe T., Omata M. Interaction between the HCV NS3 protein and the host TBK1 protein leads to inhibition of cellular antiviral responses. Hepatology 2005, 41:1004-1012.